Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide receptors and GLP-1 receptors simultaneously
Less of a roller coaster
Designed for effective appetite control, improved metabolism, and sustainable weight loss, compounded Tirzepatide offers a tailored solution at a more accessible price than branded alternatives
Our NAD+ injection program was developed with the same patient-first standards you expect from Get Thin MD: Medical-Grade NAD+ from FDA-Registered Pharmacies Physician Supervision Throughout Your Program Personalized Dosing Based on Your Needs Seamless Integration with Your GLP-1 Protocol Ongoing Clinical Support from Our Expert Team Take the Next Step in Optimizing Your GLP-1 Results with NAD+ Injections Don't settle for fatigue, plateaus, or suboptimal results from your GLP-1 medication
clonidine ER Start with 0.1 mg q bedtime, increase by 0.1 mg/week to max of 0.2 mg bid Must be given bid for 24-hour effect
